134
Views
4
CrossRef citations to date
0
Altmetric
Original

THE CLINICAL UTILITY OF THE MATTIS DEMENTIA RATING SCALE IN ASSESSING COGNITIVE DECLINE IN ALZHEIMER'S DISEASE

&
Pages 613-627 | Received 12 Mar 2005, Published online: 07 Jul 2009

REFERENCES

  • Almkvist O. Neuropsychological features of early Alzheimer's disease: Preclinical and clinical stages. Acta Neurologica Scandinavica 1996; 93(165)63–71, [CSA]
  • Almkvist O., Backman L. Progression in Alzheimer's Disease: Sequencing of Neuropsychological Decline. International Journal of Geriatric Psychiatry 1993; 8: 755–763, [CSA], [CROSSREF]
  • Brooks J., Kraemer H., Tanke E., Yesavage J. The methodology of studying decline in Alzheimer's Disease. Journal of the American Geriatrics Society 1993; 41: 623–628, [INFOTRIEVE], [CSA]
  • Chapman S., Zientz J., Weiner M., Rosenberg R., Frawley W., Burns M. Discourse changes in early Alzheimer disease, mild cognitive impairment, and normal aging. Alzheimer Disease & Associated Disorders 2002; 16: 177–186, [CSA], [CROSSREF]
  • Chertkow H., Bub D. Semantic memory loss in dementia of Alzheimer's type. What do various measures measure?. Brain 1990; 113: 397–417, [INFOTRIEVE], [CSA]
  • Chui H., Teng E., Henderson V., Moy A. Clinical subtypes of dementia of the Alzheimer type. Neurology 1985; 35: 1544–1550, [INFOTRIEVE], [CSA]
  • Coblentz J., Mattis S., Zingesser L., Kasoff S., Wisniewski H., Katzman R. Presenile dementia: Clinical aspects and evaluation of cerebrospinal fluid dynamics. Archives of Neurology 1973; 29(5)299–308, [INFOTRIEVE], [CSA]
  • de Leon M., George A., Stylopoulos L., Smith G., Miller D. Early marker for Alzheimer's disease: The atrophic hippocampus. Lancet 1989; 2: 672–673, [INFOTRIEVE], [CSA], [CROSSREF]
  • Deweer B., Lehericy S., Pillon B., Baulac M., Chiras J., Marsault C., Agid Y., Dubois B. Memory disorders in probable Alzheimer's disease: The role of hippocampal atrophy as shown with MRI. Journal of Neurology, Neurosurgery & Psychiatry 1995; 58: 590–597, [CSA]
  • Grady C., Haxby J., Horowitz B., Sundaram M., Berg G., Schapiro M., Friedland R., Rapoport S. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. Journal of Clinical and Experimental Neuropsychology 1988; 10: 576–596, [INFOTRIEVE], [CSA]
  • Hart S. Languange and dementia: A review. Archives of Neurology 1988; 53: 1072–1078, [CSA]
  • Haxby J., Raffaele K., Gillette J., Schpiro M., Rapoport S. Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. Journal of Clinical and Experimental Neuropsychology 1992; 14: 575–592, [INFOTRIEVE], [CSA]
  • Helmes E., Merskey H., Fox H., Fry R., Bowler J., Hachinski V. Patterns of deterioration in senile dementia of the Alzheimer type. Archives of Neurology 1995; 52: 306–310, [INFOTRIEVE], [CSA]
  • Helmes E., Merksey H., Fox H., Bowler J., Hachinski V. Profiles of cognitive decline in alzheimer disease. Alzheimer's Disease & Associated Disorders 2002; 16(2)123–127, [CSA], [CROSSREF]
  • Heyman A., Wilkinson W., Hurwitz B., Helms M., Haynes C., Utley C., Gwyther L. Early-onset Alzheimer's disease: Clinical predictors of institutionalization and death. Neurology 1987; 37: 980–984, [INFOTRIEVE], [CSA]
  • Ho G., Hansen L., Alford M., Foster K., Salmon D., Galasko D., Thal L., Masliah E. Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease. Neuroreport 2002; 13(14)825–828, [CSA]
  • Hodges J., Patterson K. Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications. Neuropsychologia 1995; 33: 441–459, [INFOTRIEVE], [CSA], [CROSSREF]
  • Hodges J., Salmon D., Butters N. The nature of the naming deficit in Alzheimer's and Huntington's disease. Brain 1991; 114: 1547–1558, [INFOTRIEVE], [CSA]
  • Hyman B., Van Horsen G., Damasio A., Barnes C. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science 1984; 225: 1168–1170, [INFOTRIEVE], [CSA]
  • Koss E., Edland S., Fillenbaum G., Mohs R., Clark C., Galasko D., Morris J. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, part XII. Neurology 1996; 46: 136–141, [INFOTRIEVE], [CSA]
  • Kramer-Ginsberg E., Mohs R., Aryan M., Lobel D., Silverman J., Davidson M., Davis K. Clinical predictors of course for Alzheimer's patients in a longitudinal study: A preliminary report. Psychopharmacology Bulletin 1988; 3: 458–462, [CSA]
  • Lucca U., Comelli M., Tettamanti M., Tiraboschi P., Spagnoli A. Rate of progression and prognostic factors in Alzheimer's disease: A prospective study. Journal of the American Geriatrics Society 1993; 41: 45–49, [INFOTRIEVE], [CSA]
  • Mattis S. Dementia Rating Scale Professional Manual, et al. Psychological Assessment Resources, Odessa, FL 1988
  • Mattis S., Jurica P., Leitten C. Dementia Rating Scale-2 Professional Manual, et al. Psychological Assessment Resources, Odessa, FL 2002
  • Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Annals of Nuclear Medicine 2001; 15(2)85–92, [INFOTRIEVE], [CSA]
  • McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944, [INFOTRIEVE], [CSA]
  • Monsch A., Bondi M., Butters N., Salmon D., Katzman R., Thal L. Comparison of verbal fluency tasks in the detection of dementia of the Alzheimer type. Archives of Neurology 1992; 49: 1253–1258, [INFOTRIEVE], [CSA]
  • Monsch A., Bondi M., Salmon D., Butters N., Thal L., Hansen L., Wiederholt W., Cahn D., Klauber M. Clinical validity of the Mattis Dementia Rating Scale in detecting dementia of the Alzheimer type: A double cross-validation and application to a community-dwelling sample. Archives of Neurology 1995; 52: 899–904, [INFOTRIEVE], [CSA]
  • Orange J., Van Gennep K., Miller L., Johnson A. Resolution of communication breakdown in dementia of the Alzheimer's type: A longitudinal study. Journal of Applied Communication Research 1998; 26: 120–138, [CSA]
  • Ortof E., Crystal H. Rate of progression of Alzheimer's disease. Journal of the American Geriatrics Society 1989; 37: 511–514, [PUBMED], [INFOTRIEVE], [CSA]
  • Price B., Gurvit H., Weintraub S., Geula C., Leimkuhler E., Mesulam M. Neuropsychological patterns and language deficits in 20 consecutive cases of autopsy-confirmed Alzheimer's disease. Archives of Neurology 1993; 50: 931–937, [INFOTRIEVE], [CSA]
  • Ralph M., Powell J., Howard D., Whitworth A., Garrard P., Hodges J. Semantic memory is impaired in both dementia with Lewy bodies and dementia of the Alzheimer's type: A comparative neuropsychoplogical study and literature review. Journal of Neurology, Neurosurgery, & Psychiatry 2001; 70: 149–156, [CSA], [CROSSREF]
  • Reid W., Broe G., Creasey H., Grayson D., McCusker E., Bennett H., Longley W., Sulway M. Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease: A study of a community-based population. Archives of Neurology 1996; 53: 1056–1061, [INFOTRIEVE], [CSA]
  • Salmon D., Butters N., Chan A. The deterioration of semantic memory in Alzheimer's disease. Canadian Journal of Experimental Psychology 1999; 53: 108–117, [INFOTRIEVE], [CSA]
  • Salmon D., Thal L., Butters N., Heindel W. Longitudinal evaluation of dementia of the Alzheimer type: A comparison of 3 standardized mental status examinations. Neurology 1990; 40: 1225–1230, [INFOTRIEVE], [CSA]
  • Seltzer B., Sherwin I. A comparison of clinical features in early and late onset primary degenerative dementia, one entity or two? Archives of Neurology 1983; 40: 143–146, [INFOTRIEVE], [CSA]
  • Shay K., Duke L., Conboy T., Harrell L., Callaway R., Folks D. The clinical validity of the Mattis Dementia Rating Scale. Journal of Geriatric Psychiatry and Neurology 1991; 4: 18–25, [INFOTRIEVE], [CSA]
  • Small B., Fratiglioni L., Viitanen M., Winblad B., Backman L. The course of cognitive impairment in preclinical Alzheimer disease. Archives of Neurology 2000; 57: 839–844, [INFOTRIEVE], [CSA], [CROSSREF]
  • Smith Doody R., Massman P., Dunn J. A method for estimating progression rates in Alzheimer disease. Archives of Neurology 2001; 58: 449–454, [CSA], [CROSSREF]
  • Stern R., Mohs R., Davidson M., Schmeidler J., Silverman J., Kramer-Ginsberg E., Searcey T., Bierer L., Davis K. A longitudinal study of Alzheimer's disease: Measurement, rate, and predictors of cognitive deterioration. American Journal of Psychiatry 1994; 151: 390–396, [INFOTRIEVE], [CSA]
  • Sullivan E., Shear P., Mathalon D., Lim K., Yesavage J., Tinklenberg J., Pfefferbaum A. Greater abnormalities of brain cerebrospinal fluid volumes in younger than in older patients with alzheimer's disease. Archives of Neurology 1993; 50: 359–373, [INFOTRIEVE], [CSA]
  • van Gorp W., Marcotte T., Sultzer D., Hinkin C., Mahler M., Cummings J. Screening for dementia: Comparison of three commonly used instruments. Journal of Clinical and Experimental Neuropsychology 1999; 21: 29–38, [INFOTRIEVE], [CSA]
  • Vitaliano P., Breen A., Russo J., Albert M., Vitiello M., Prinz P. The clinical utility of the Dementia Rating Scale for assessing Alzheimer patients. Journal of Chronic Disabilities 1984; 37: 743–753, [CSA], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.